Clinical trial
Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients
NCT03300739 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- September 30, 2019
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, copd exacerbation